New prehospital transfusion bundle aims to control bleeding in trauma patients
NCT ID NCT06891131
First seen Jan 04, 2026 · Last updated May 19, 2026 · Updated 23 times
Summary
This study tests whether giving a combination of blood products (fibrinogen, plasma, and tranexamic acid) to trauma patients with life-threatening bleeding before they arrive at the hospital is feasible. Ten adults with signs of hemorrhagic shock will be included. The goal is to see if this approach can be successfully implemented and to gather early data on survival and blood use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAEMORRHAGIC SHOCK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Medical University of Graz
RECRUITINGGraz, 8043, Austria
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.